In 2015, the WHO’s International Agency for Research on Cancer (IARC) classified glyphosate, Roundup’s main ingredient, as “probably carcinogenic in humans” based on various human, animal and in vitro studies.
Specifically, exposure to glyphosate was linked to an increased risk of non-Hodgkin’s lymphoma, a type of cancer that affects the lymphatic system.
Complete the form below to find out if you or someone in your family qualify for compensation.
"*" indicates required fields
While the EPA and FDA have concluded that glyphosate is safe for human use, multiple studies have uncovered evidence supporting the WHO’s findings. Researchers have observed anywhere from a 41 to 70% increased risk for non-Hodgkin’s lymphoma after prolonged exposure to Roundup.
Non-Hodgkin’s lymphoma occurs when your body creates too many abnormal white blood cells. It impacts the lymphatic system, which is part of your germ-fighting immune system. As white blood cells grow abnormally, tumors may begin to form throughout the body.
Non-Hodgkin’s lymphoma is just a category of lymphoma, with many subtypes that fall under it. Recovery and survival rates vary between the types and an individual’s situation, but advances in treatment options have helped improve the prognosis for those diagnosed.
Symptoms include:
No fees unless you are awarded compensation.
